Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0085383 (hypocapnia)
 1,697 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The effects of carbon dioxide (PCO2 = 40 versus PCO2 = 20) on pulmonary function changes during 2 hours of hemorrhagic hypotension followed by resuscitation are evaluated in 21 dogs. Pulmonary hemodynamics, mechanics, gas exchange, functional residual capacity, and morphology are studied. In the preshock period, hypocapnia is associated with a decreased cardiac output, increased dead space, and increased alveolar-arterial (A-a) gradiant (room air). During the period of hypotension, all parameters in both groups changed similarly. After resuscitation, the A-a gradients in the two groups further widened. Following the return to control levels of normocapnia in all animals, the group which had been hypocapnic during the hypotensive episode continued to show increased shunting (20 versus 13 percent, p less than 0.05). These results correlated well with cinemicroscopic findings, which showed the normocapnic group to have less interstitial edema and better capillary flow.
J Thorac Cardiovasc Surg 1977 Jul
PMID:The role of carbon dioxide in the development of pulmonary insufficiency. 87 28

The effects of hypercapnia and hypocapnia on haemodynamics, coronary blood flow, and lactate metabolism were evaluated in anaesthetized closed chest dogs. Coronary flow increased with increased pCO2 and oxygen consumption and left ventricular performance were well maintained. Hypocapnia reduced coronary flow, oxygen consumption, and left ventricular functional performance.
Cardiovasc Res 1976 May
PMID:Effect of hypercapnia and hypocapnia on myocardial blood flow and performance in anaesthetized dogs. 95 18

A new method for measuring blood flow in the colon using a 133Xenon clearance technique has been developed in the greyhound. Values for 133Xe tissue blood partition coefficient for colon have been established. The mean basal colon blood flow in 35 animals was 39.8 cm3.min-1.100g-1 with a coefficient of variation for repeat measurements of 8.7%. Hypercapnia produced a significant rise in colon blood flow to a mean maximum level of 62.2 cm3.min-1.100g-1 and hypocapnia a significant fall to a mean level of 27.9 cm3.min-1.100g-1. For arterial carbon dioxide tension (PCO2) values between 2 and 12 kPa (15 and 90 mmHg) there was a straight line relationship between colon blood flow and arterial PCO2. When hypercapnia was prolonged for 75 min, the initial rise in colon blood flow was only partially sustained, while prolonged hypocapnia for a similar period resulted in sustained reduction in flow. Mean resting colon oxygen consumption in 35 animals was 1.17 cm3.min-1.100g-1 and this was not significantly affected by hypocapnia. Hypercapnia to arterial PCO2 levels between 8 and 14 kPa (60 and 105 mmHg), however, produced a significant rise in colon oxygen consumption. Since changes in colon blood flow during and after surgery may affect healing of colonic anastomoses, these results may be relevant when considering anaesthetic techniques for patients undergoing colon resection.
Cardiovasc Res 1980 Jan
PMID:Colon blood flow in the dog: effects of changes in arterial carbon dioxide tension. 676 45

Heart failure is a highly prevalent disorder, with significant economic impact, and is associated with excess morbidity and mortality. One factor that may contribute to the progressively declining course of heart failure is the occurrence of recurrent episodes of apnea and hypopnea. There are two major kinds of sleep-related breathing disorders: obstructive and central sleep apnea. In patients with heart failure, in contrast to the general population, central sleep apnea is the most common form of sleep-related breathing disorder. Episodes of apnea, hypopnea, and the subsequent hyperpnea cause sleep disruption, arousals, hypoxemia-reoxygenation, hypercapnia/hypocapnia, and changes in intrathoracic pressure. These pathophysiologic consequences of sleep-related breathing disorders have deleterious effects on the cardiovascular system, and may be even more pronounced in the setting of established heart failure and coronary artery disease. Therefore, sleep apnea in heart failure should be treated. Central sleep apnea may be treated with nocturnal supplemental nasal oxygen, theophylline, or nasal-positive pressure devices, such as nasal continuous positive airway pressure (CPAP). The treatment of choice for obstructive sleep apnea is nasal CPAP. Although long-term controlled trials of the effect of treatment of sleep apnea on mortality in patients with heart failure are still pending, treatment of sleep apnea, both obstructive and central, does result in a decrease in sympathetic activity and an improvement in systolic function, which are known surrogates of mortality. Therefore, diagnosis and treatment of sleep-related breathing disorders may increase survival of patients with heart failure.
Curr Treat Options Cardiovasc Med 2005 Aug
PMID:Prevalence and treatment of breathing disorders during sleep in patients with heart failure. 1600 60